Clarithromycin Versus Metronidazole in First-Line <i>Helicobacter Pylori</i> Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis
Background: International treatment guidelines for <i>Helicobacter pylori</i> infection recommend a proton pump inhibitor (PPI)/amoxicillin/clarithromycin (CAM) regimen (PAC) or PPI/amoxicillin/metronidazole (MNZ) regimen (PAM) as first-line therapy based on culture and sensitivity testi...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/2/543 |